Found: 11
Select item for more details and to access through your institution.
Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1102384
- By:
- Publication type:
- Article
SM-COLSARSPROT: Highly Immunogenic Supramutational Synthetic Peptides Covering the World's Population.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.859905
- By:
- Publication type:
- Article
Atorvastatin Effectively Inhibits Ancestral and Two Emerging Variants of SARS-CoV-2 in vitro.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.721103
- By:
- Publication type:
- Article
Development of an optimized method for processing peripheral blood mononuclear cells for <sup>1</sup>H-nuclear magnetic resonance-based metabolomic profiling.
- Published in:
- PLoS ONE, 2021, v. 16, n. 2, p. 1, doi. 10.1371/journal.pone.0247668
- By:
- Publication type:
- Article
Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms.
- Published in:
- Molecules, 2021, v. 26, n. 22, p. 6900, doi. 10.3390/molecules26226900
- By:
- Publication type:
- Article
PM10 promotes an inflammatory cytokine response that may impact SARS-CoV-2 replication in vitro.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1161135
- By:
- Publication type:
- Article
Corozo (Bactris guineensis) fruit extract has antiviral activity in vitro against SARS-CoV-2.
- Published in:
- Functional Foods in Health & Disease, 2022, v. 12, n. 9, p. 534, doi. 10.31989/ffhd.v12i9.918
- By:
- Publication type:
- Article
In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach.
- Published in:
- AIMS Microbiology, 2023, v. 9, n. 1, p. 20, doi. 10.3934/microbiol.2023002
- By:
- Publication type:
- Article
Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2022.1102384
- By:
- Publication type:
- Article
NK cells from Men Who Have Sex with Men at high risk for HIV-1 infection exhibit higher effector capacity.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-44054-1
- By:
- Publication type:
- Article
NK cells from Men Who Have Sex with Men at high risk for HIV-1 infection exhibit higher effector capacity.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-44054-1
- By:
- Publication type:
- Article